1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. ERYTECH Pharma S.A.
  6. News
  7. Summary
    ERYP   FR0011471135

ERYTECH PHARMA S.A.

(ERYP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Nudge Lower in Tuesday Trading

12/28/2021 | 11:16am EDT


ę MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC 4.44% 1.41 Delayed Quote.-62.40%
AMARIN CORPORATION PLC 19.20% 1.49 Delayed Quote.-55.79%
BHP GROUP LIMITED -1.16% 45.31 Delayed Quote.10.46%
BIOFRONTERA AG 1.45% 1.05 Delayed Quote.-30.07%
CARNIVAL CORPORATION 7.69% 14.28 Delayed Quote.-29.03%
DBV TECHNOLOGIES -2.18% 2.42 Real-time Quote.-19.12%
ERYTECH PHARMA S.A. -2.54% 1.15 Real-time Quote.-44.34%
GENFIT -0.50% 3.162 Real-time Quote.-26.37%
NUCANA PLC -0.15% 0.59 Delayed Quote.-75.21%
ORPHAZYME A/S -0.66% 2.098 Delayed Quote.-87.69%
SPARK NETWORKS SE 8.02% 2.02 Delayed Quote.-35.67%
TRINITY BIOTECH PLC 1.74% 1.17 Delayed Quote.-18.18%
VERONA PHARMA PLC 5.63% 3.75 Delayed Quote.-44.20%
VIA OPTRONICS AG -3.08% 3.12 Delayed Quote.-57.55%
All news about ERYTECH PHARMA S.A.
05/13TRANSCRIPT : ERYTECH Pharma S.A., Q1 2022 Earnings Call, May 13, 2022
CI
05/12ERYTECH Provides Business and Financial Update for the First Quarter of 2022
GL
05/12ERYTECH Provides Business and Financial Update for the First Quarter of 2022
AQ
05/10European ADRs Move Higher in Tuesday Trading
MT
05/02European ADRs Move Slightly Lower in Monday Trading
MT
04/29European ADRs Nudge Higher in Friday Trading
MT
04/28ERYTECH Announces Filing of 2021 Universal Registration Document and 2021 Annual Report..
GL
04/28ERYTECH Announces Filing of 2021 Universal Registration Document and 2021 Annual Report..
AQ
04/28European ADRs Nudge Lower in Thursday Trading
MT
04/28ERYTECH PHARMA S A : ASSET PURCHASE AGREEMENT - Form 6-K
PU
More news
Analyst Recommendations on ERYTECH PHARMA S.A.
More recommendations
Financials
Sales 2022 23,5 M 24,5 M 24,5 M
Net income 2022 -53,7 M -55,8 M -55,8 M
Net Debt 2022 59,8 M 62,2 M 62,2 M
P/E ratio 2022 -0,69x
Yield 2022 -
Capitalization 36,6 M 38,1 M 38,1 M
EV / Sales 2022 4,10x
EV / Sales 2023 1,39x
Nbr of Employees 181
Free-Float 98,5%
Chart ERYTECH PHARMA S.A.
Duration : Period :
ERYTECH Pharma S.A. Technical Analysis Chart | ERYP | FR0011471135 | MarketScreener
Technical analysis trends ERYTECH PHARMA S.A.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus SELL
Number of Analysts 1
Last Close Price 1,18 €
Average target price 5,80 €
Spread / Average Target 392%
EPS Revisions
Managers and Directors
Gil Beyen Chief Executive Officer & Director
Eric Soyer Chief Operating & Financial Officer
Jean-Paul Kress Chairman
Iman El-Hariry Chief Medical Officer
Stewart Craig Chief Technical Officer
Sector and Competitors
1st jan.Capi. (M$)
ERYTECH PHARMA S.A.-44.34%38
GILEAD SCIENCES, INC.-14.10%78 232
REGENERON PHARMACEUTICALS, INC.2.22%69 552
VERTEX PHARMACEUTICALS12.35%63 100
WUXI APPTEC CO., LTD.-14.92%43 023
BIONTECH SE-38.39%38 601